Gerresheimer begins financial year 2013 with strong revenue growth

Düsseldorf (ots) -

- Cross reference: The full press release including tables is
available at http://www.presseportal.de/dokumente -

- First-quarter revenues up 10.4% to EUR 296.7m
- Adjusted EBITDA margin reaches 15.5%
- Net income grows by 41.7% to EUR 10.2m
- Adjusted earnings per share increased to EUR 0.36
- Acquisition in India boosts activities in emerging markets

Gerresheimer AG, one of the leading global partners to the pharma
and healthcare industry, increased revenues by 10.4% in the first
quarter of the new, 2013 financial year. "The strong revenue growth
in the first quarter largely relates to increased revenues in the
Plastic Systems Division. The increase is mostly attributable to
higher revenues from engineering services and tools paving the way
for future business with drug delivery devices. Our latest
acquisitions in India also contributed to the surge in revenues.
There is furthermore healthy demand for pharma products overall,"
said Uwe Röhrhoff, CEO of Gerresheimer AG.

Gerresheimer increased revenues in the first quarter of financial
year 2013 (December 1, 2012 to November 30, 2013) by a substantial
10.4% to EUR 294.7m. The revenue increase was due primarily to strong
organic growth in the Plastic Systems Division. This notably
generated large revenues with tools and engineering services. There
was also favorable demand for drug delivery devices such as insulin
pens, asthma inhalers and prefillable glass syringes. Sound revenues
were also attributable to primary pharma packaging such as glass
injection vials, cartridges as well as plastic containers for solid
and liquid medications. The two Indian companies acquired in 2012 -
Triveni, a producer of plastic primary pharmaceutical packaging, and
Neutral Glass, which produces glass pharmaceutical vials - also
contributed to the marked revenue increase compared with the prior
year.

The Gerresheimer Group generated adjusted EBITDA of EUR 46.0m in
the first quarter of 2013, an increase of 2.1% on the prior-year
quarter. The adjusted EBITDA margin was 15.5%, below the 16.8% margin
in the comparative period. The main reason for the lower margin was
the exceptionally strong revenue growth in engineering services and
tools business in the Plastic Systems Division. While the tools
business and engineering services have narrower margins, they are
important in paving the way for the subsequent production of drug
delivery devices. Net income after tax increased relative to the
prior-year quarter by 41.7% to EUR 10.2m. Adjusted earnings per share
rose by EUR 0.03 to EUR 0.36.

Gerresheimer's capital expenditure in the first quarter of 2013
was EUR 16.6m, EUR 1.7m more than a year earlier. In December 2012,
Gerresheimer also purchased 75% of shares in Triveni, the leading
Indian producer of pharmaceutical plastic packaging and closures.

Outlook

For financial year 2013, Gerresheimer continues to anticipate
revenue growth of 5% to 6% at constant exchange rates, even though
this forecast seems slightly more conservative now against the
background of the strong revenue growth in the first quarter of 2013.
The company expects to generate an adjusted EBITDA margin of
approximately 19.4%. Due to the healthy growth prospects, capital
expenditure in financial year 2013 will be on a par with the past
financial year, meaning some 9% to 10% of the revenue at constant
exchange rates.

"Of key importance is the expansion of our production capacity for
glass and plastic medical application systems at our Bünde and
Pfreimd plants in Germany and our Horsovsky Tyn plant in the Czech
Republic. The second major growth factor consists in boosting local
production for primary glass and plastic pharma packaging in dynamic
emerging markets," explained Uwe Röhrhoff.

The Gerresheimer Group has elected early application of IAS 19
Employee Benefits (revised 2011) with effect from December 1, 2012.
Prior-year figures in tables in this press release and the Interim
Report are therefore pro forma. Detailed information on the effects
of the restatements is provided in the Notes section of the Interim
Report.

The online annual report is available at:
http://annualreport2012.gerresheimer.com

Contact:
Jens Kürten
Director Corporate Communication & Marketing
Telphone +49 211 6181-250
Fax +49 211 6181-241
E-Mail j.kuerten@gerresheimer.com
Internet www.gerresheimer.com